OPKO Health
OPK
#6383
Rank
HK$7.22 B
Marketcap
HK$9.57
Share price
4.27%
Change (1 day)
-12.94%
Change (1 year)

OPKO Health (OPK) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : HK$5.11 Billion

According to OPKO Health 's latest financial reports the company's total liabilities are HK$5.11 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

OPKO Health - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31HK$5.16 B-20.28%
2024-12-31HK$6.48 B33.3%
2023-12-31HK$4.86 B2.74%
2022-12-31HK$4.73 B-15.08%
2021-12-31HK$5.57 B-10.32%
2020-12-31HK$6.21 B14.87%
2019-12-31HK$5.40 B4.69%
2018-12-31HK$5.16 B-11.39%
2017-12-31HK$5.83 B11.43%
2016-12-31HK$5.23 B-17.6%
2015-12-31HK$6.35 B89.57%
2014-12-31HK$3.35 B-16.68%
2013-12-31HK$4.02 B499.36%
2012-12-31HK$0.67 B95.33%
2011-12-31HK$0.34 B-19.45%
2010-12-31HK$0.42 B-1.5%
2009-12-31HK$0.43 B161.72%
2008-12-31HK$0.16 B-6.89%
2007-12-31HK$0.17 B23943.29%
2006-12-31HK$0.73 M-65.6%
2005-12-31HK$2.14 M15.15%
2004-12-31HK$1.86 M-76.82%
2003-12-31HK$8.04 M-28.4%
2002-12-31HK$11.23 M-4.18%
2001-12-31HK$11.72 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
HK$938.67 B 18,254.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$452.66 B 8,751.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
HK$74.06 B 1,348.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$520.46 B 10,077.16%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
HK$81.09 B 1,485.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$31.79 B 521.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$249.41 B 4,777.14%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Ardelyx
ARDX
HK$2.79 B-45.43%๐Ÿ‡บ๐Ÿ‡ธ USA